| Closed |
SWOG-8917 |
5-Fluorouracil, Leucovorin and Roferon-A® in Advanced Colorectal Cancer, Phase II Pilot |
12/1/1989 |
2/15/1992 |
100% |
|
Published
|
| Closed |
SWOG-8017 |
5-FU, Adriamycin, Streptozotocin and Cyclophosphamide (FAC-S) in the Treatment of Metastatic Carcinoid Tumors |
7/7/1980 |
1/19/1984 |
|
|
Published
|
| Closed |
SWOG-425/426 |
6-Mercaptopurine (NSC-755) and 6-Methylmercaptopurine Riboside (NSC-40774) Combination in the Treatment of Adult Acute Leukemia |
|
11/4/1969 |
9% |
|
|
| Closed |
SWOG-8210 |
A Comparison of Aggressive Radiotherapy Plus Chemo- therapy Versus Aggressive Chemotherapy in the Treatment of Limited Carcinoma of the Pancreas |
9/17/1982 |
3/16/1984 |
|
|
|
| Closed |
SWOG-9006 |
A Phase II 19F Magnetic Resonance Spectroscopy (MRS) Study of 5-FU and Correlation with Clinical Results of 5-FU/Leucovorin (LV) Therapy in Patients with Carcinomas of the Gastrointestinal Tract |
10/15/1990 |
11/1/1996 |
77% |
|
Published
|
| Closed |
SWOG-9107 |
A Phase II Pilot Study of High Dose 24-Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA for Patients with Colorectal Cancer |
1/1/1993 |
8/1/1994 |
70% |
|
Published
|
| Closed |
SWOG-9100 |
A Phase II Pilot Study of High-Dose 24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose PALA in Patients with Pancreatic Adenocarcinoma |
1/15/1993 |
8/1/1994 |
86% |
|
Published
|
| Closed |
SWOG-8832 |
A Phase II Study of Continuous Infusion Recombinant Interleukin-2 (rIL-2) in Patients with Pancreatic Cancer |
4/1/1989 |
11/15/1990 |
6% |
|
|
| Closed |
SWOG-8760 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Gastric Carcinoma |
6/15/1988 |
1/1/1990 |
83% |
|
Published
|
| Closed |
SWOG-8743 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients with Metastatic Colorectal Adenocarcinoma |
6/15/1988 |
1/1/1990 |
71% |
|
Published
|
| Closed |
SWOG-8755 |
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) In Patients With Pancreatic Adeno-carcinoma |
6/15/1988 |
1/1/1990 |
|
|
Published
|
| Closed |
SWOG-9511 |
A Phase II Study of Trimetrexate, 5-FU and Leucovorin in Unresectable or Metastatic Adenocarcinoma of the Stomach |
1/15/1997 |
11/15/1998 |
100% |
|
Published
|
| Closed |
S9629 |
A Phase II Trial of 5-Fluorouracil Plus 776C85 in Patients with Advanced Pancreas Cancer |
5/15/1997 |
3/15/1999 |
100% |
|
Published
|
| Closed |
SWOG-9135 |
A Phase II Trial of Taxol and Granulocyte-Colony Stimulating Factor (G-CSF) in Patients with Pancreatic Adenocarcinoma |
6/1/1992 |
1/15/1993 |
|
|
Published
|
| Closed |
SWOG-8721 |
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer |
9/1/1987 |
9/1/1991 |
69% |
|
Published
|
| Closed |
SWOG-8623 |
A Phase II Trial of Trimetrexate in Untreated Advanced Gastric Carcinoma |
8/15/1987 |
1/1/1989 |
|
|
Published
|
| Closed |
SWOG-9420 |
A Phase III Trial of Continuous Low-Dose Infusion versus Intermittent High-Dose Infusion of 5-Fluorouracil in Patients with Disseminated Colorectal Cancer |
4/15/1995 |
5/15/1999 |
100% |
|
Published
|
| Closed |
SWOG-8712 |
A Phase ll Trial of Trimetrexate in the Treatment of Hepatoma |
7/15/1987 |
1/1/1989 |
|
|
Published
|
| Closed |
SWOG-9060 |
A Pilot Study Evaluation of Multimodality Treatment of Local Regional Esophageal Carcinoma, Phase II |
11/1/1991 |
3/1/1993 |
100% |
|
Published
|
| Closed |
SWOG-8611 |
A Randomized Trial of Two Schedules of Trimetrexate Versus 5-Fluorouracil in Colorectal Carcinoma |
1/15/1987 |
11/15/1988 |
|
|
Published
|
